Multidrug transporter MexB of Pseudomonas aeruginosa: overexpression, purification, and initial structural

Vladislav Mokhonov1, Ekaterina Mokhonova, Eisaku Yoshihara

  • 1Department of Molecular Life Science, Tokai University, School of Medicine, 143 Shimokasuya, Isehara 259-1193, Japan.

Insights

Researchers developed a large-scale system to produce the MexB multidrug transporter from Pseudomonas aeruginosa in Escherichia coli, achieving higher yields for structural studies. This optimized production and purification method yields stable, homogeneous MexB, suitable for further characterization.

Area of Science:

  • Microbiology
  • Structural Biology
  • Biochemistry

Background:

  • The multidrug transporter MexB from Pseudomonas aeruginosa is crucial for antibiotic resistance.
  • Low natural yields of MexB hinder structural and functional studies, limiting understanding of its mechanism.

Purpose of the Study:

  • To develop a scalable system for high-yield recombinant MexB expression in Escherichia coli.
  • To establish an optimized purification protocol for homogeneous MexB suitable for structural analysis.

Main Methods:

  • Genetically engineered recombinant MexB expression in Escherichia coli.
  • Large-scale culture and optimized purification using dodecyl beta-D-maltoside.
  • Oligomeric state determination via molecular mass and mass ratio analysis.
  • Circular dichroism spectroscopy for secondary structure analysis.

Main Results:

  • Achieved a MexB yield of approximately 10 mg/L, a significant increase from natural sources.
  • Isolated highly homogeneous MexB protein, preserving its native state.
  • Determined that purified MexB exists as a homotrimer in dodecyl beta-D-maltoside solution.
  • Circular dichroism confirmed a high alpha-helix content in MexB structure.

Conclusions:

  • The developed large-scale expression and purification system provides high-yield, homogeneous, and stable MexB.
  • The purified MexB is well-suited for detailed structural and functional characterization.
  • This advancement facilitates research into MexB's role in multidrug resistance and potential therapeutic targeting.